Overview

Effect of Nebulized and Intravenous Hypertonic Saline 3% on the Management of Patients With Acute Respiratory Distress Syndrome

Status:
RECRUITING
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
The aim of our study is to compare between the effect of nebulized and intravenous injection of hypertonic saline 3% on the outcome of patients with acute respiratory distress syndrome.
Phase:
NA
Details
Lead Sponsor:
Tanta University
Treatments:
Nebulizers and Vaporizers
Saline Solution, Hypertonic